Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CVRx (CVRX) Research & Development (2020 - 2026)

CVRx has reported Research & Development over the past 7 years, most recently at $3.1 million for Q1 2026.

  • For Q1 2026, Research & Development rose 22.53% year-over-year to $3.1 million; the TTM value through Mar 2026 reached $11.7 million, up 10.46%, while the annual FY2025 figure was $11.1 million, 0.01% changed from the prior year.
  • Research & Development for Q1 2026 was $3.1 million at CVRx, up from $3.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $3.4 million in Q1 2023 and troughed at $2.2 million in Q4 2023.
  • A 5-year average of $2.8 million and a median of $2.8 million in 2024 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: surged 69.5% in 2022 and later dropped 26.43% in 2023.
  • Year by year, Research & Development stood at $3.0 million in 2022, then dropped by 26.43% to $2.2 million in 2023, then rose by 25.17% to $2.8 million in 2024, then rose by 6.95% to $3.0 million in 2025, then rose by 2.8% to $3.1 million in 2026.
  • Business Quant data shows Research & Development for CVRX at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $3.1 million in Q3 2025.